Introduction COVID-19 vaccines have been highly effective in reducing morbidity and
mortality during the pandemic. While primary series vaccination rates are generally high in …

Introduction COVID-19 vaccines have been highly effective in reducing morbidity and mortality
during the pandemic. However, the emergence of the Omicron variant and subvariants as …

Background MVC-COV1901, a recombinant protein vaccine containing pre-fusion-stabilised
spike protein S-2P adjuvanted with CpG 1018 and aluminium hydroxide, has been shown …

Coronavirus disease-19 (COVID-19) is an emerging infectious disease caused by SARS-CoV-2
that has rapidly evolved into a pandemic to cause over 600 million infections and more …

Background The Delta and Omicron variants of SARS-CoV-2 are currently responsible for
breakthrough infections due to waning immunity. We report phase I/II trial results of UB-612, a …

To find new candidate loci predisposing individuals to Kawasaki disease, an acute vasculitis
that affects children, we conducted a genome-wide association study in 622 individuals …

Kawasaki disease (KD) is a systemic febrile vasculitis particular coronary artery involvement.
Eosinophilia has been found in our and other studies in KD. This study further investigates …

Background and purpose This study investigated the clinical manifestations and risk factors
for dengue fever (DF) and dengue hemorrhagic fever (DHF) and disease severity during the …

Methicillin-resistant Staphylococcus aureus (MRSA) has been identified as a major cause of
community-associated (CA) S. aureus infections in the past decade. The main reservoir in …

Objectives: Kawasaki disease (KD) is a systemic vasculitis primarily affecting children who
are <5 years old. Intravenous immunoglobulin (IVIG) is the standard therapy for KD. However, …